Order Article Reprints

Hetland G, Fagerhol MK, Mirlashari MR, Nissen-Meyer LSH, Croci S, Lonati PA, Bonacini M, Salvarani C, Marvisi C, Bodio C, et al. Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy. Biomedicines. 2024; 12(4):766. https://doi.org/10.3390/biomedicines12040766

Hetland, Geir, Magne Kristoffer Fagerhol, Mohammad Reza Mirlashari, Lise Sofie Haug Nissen-Meyer, Stefania Croci, Paola Adele Lonati, Martina Bonacini, Carlo Salvarani, Chiara Marvisi, Caterina Bodio, and et al. 2024. "Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy" Biomedicines 12, no. 4: 766. https://doi.org/10.3390/biomedicines12040766

Hetland, G., Fagerhol, M. K., Mirlashari, M. R., Nissen-Meyer, L. S. H., Croci, S., Lonati, P. A., Bonacini, M., Salvarani, C., Marvisi, C., Bodio, C., Muratore, F., Borghi, M. O., & Meroni, P. L. (2024). Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy. Biomedicines, 12(4), 766. https://doi.org/10.3390/biomedicines12040766